CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-12 | Kulkarni Samarth Chief Executive Officer | Sale | −4,462 | $43.32 | $193K | 185,428 |
| 2025-03-12 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,116 | $43.32 | $48K | 78,664 |
| 2025-03-12 | Bruno Julianne Chief Operating Officer | Sale | −190 | $43.32 | $8K | 8,508 |
| 2025-03-11 | Kulkarni Samarth Chief Executive Officer | Sale | −9,973 | $42.42 | $423K | 180,890 |
| 2025-03-11 | KASINGER JAMES R. General Counsel and Secretary | Sale | −2,850 | $42.42 | $121K | 77,530 |
| 2025-03-11 | Bruno Julianne Chief Operating Officer | Sale | −1,198 | $42.42 | $51K | 8,263 |
| 2025-02-19 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −18,360 | $55.21 | $1.0M | 171,613 |
| 2025-02-19 | Bruno Julianne Chief Operating Officer | Sale | −333 | $52.80 | $18K | 7,062 |
| 2025-02-19 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,947 | $52.80 | $103K | 74,880 |
| 2025-02-19 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −6,928 | $52.80 | $366K | 189,973 |
| 2025-02-18 | KASINGER JAMES R. General Counsel and Secretary | Sale | −9,595 | $53.85 | $517K | 73,002 |
| 2025-02-18 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −11,640 | $55.05 | $641K | 196,901 |
| 2024-12-02 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −15,000 | $55.10 | $827K | 181,540 |
| 2024-11-11 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −23,121 | $55.43 | $1.3M | 203,419 |
| 2024-11-11 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −6,879 | $56.27 | $387K | 196,540 |
| 2024-10-14 | KASINGER JAMES R. General Counsel and Secretary | Sale | −1,089 | $46.28 | $50K | 62,597 |
| 2024-10-14 | Kulkarni Samarth Chief Executive Officer | Sale | −4,293 | $46.28 | $199K | 226,540 |
| 2024-06-21 | Bruno Julianne Chief Operating Officer | Sale | −3,366 | $56.09 | $189K | 6,745 |
| 2024-04-15 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −18,378 | $59.88 | $1.1M | 209,326 |
| 2024-04-15 | Kulkarni Samarth Chief Executive Officer | Sale 10b5-1 | −1,204 | $60.40 | $73K | 208,122 |
Page 3 of 27 · 528 trades